GEORGE CHOLANKERIL to Cardiovascular Diseases
This is a "connection" page, showing publications GEORGE CHOLANKERIL has written about Cardiovascular Diseases.
Connection Strength
0.501
-
Association of High-Sensitivity Troponins in Metabolic Dysfunction-Associated Steatotic Liver Disease With All-Cause and Cause-Specific Mortality. Aliment Pharmacol Ther. 2025 Jun; 61(11):1785-1793.
Score: 0.101
-
Depression in nonalcoholic fatty liver disease and all-cause/cause-specific mortality. Eur J Clin Invest. 2024 Jan; 54(1):e14087.
Score: 0.090
-
Management of Cardiometabolic Complications in Patients With Nonalcoholic Fatty Liver Disease: A Review of the Literature With Recommendations. J Clin Gastroenterol. 2021 10 01; 55(9):747-756.
Score: 0.079
-
Physical Activity, Measured Objectively, Is Associated With Lower Mortality in Patients With Nonalcoholic Fatty Liver Disease. Clin Gastroenterol Hepatol. 2021 06; 19(6):1240-1247.e5.
Score: 0.073
-
Increasing Mortality Among Patients With Diabetes and Chronic Liver Disease From 2007 to 2017. Clin Gastroenterol Hepatol. 2020 04; 18(4):992-994.
Score: 0.068
-
Trends in overall, cardiovascular and cancer-related mortality among individuals with diabetes reported on death certificates in the United States between 2007 and 2017. Diabetologia. 2019 07; 62(7):1185-1194.
Score: 0.067
-
Estimated pulse wave velocity in metabolic dysfunction-associated steatotic liver disease and all-cause/cause-specific mortality. J Gastroenterol Hepatol. 2024 Sep; 39(9):1950-1956.
Score: 0.024